Epidemiology of vascular dementia
- PMID:7477666
- DOI: 10.1159/000109800
Epidemiology of vascular dementia
Abstract
Vascular dementia (VaD) is the second commonest dementia after Alzheimer's disease (AD). Epidemiological studies of this condition suffer from many shortcomings related to definition of the disease, diagnostic criteria and assessment of subjects. The prevalence of VaD increases linearly with age and varies greatly from country to country, ranging from 1.2 to 4.2% of people over 65 years old, even after adjustment for age and sex. The incidence of VaD is more homogeneous than prevalence and is estimated at 6-12 cases per 1,000 persons over 70 years per year. The mean duration of the disease is around 5 years and survival is less than for the general population and for AD. The major risk factors for VaD appear to be hypertension, diabetes, heart disease and stroke. Although some of these risk factors are modifiable, there is no study on efficacy of prevention of VaD.
Similar articles
- Epidemiology of vascular dementia.Leys D, Pasquier F, Parnetti L.Leys D, et al.Haemostasis. 1998 May-Aug;28(3-4):134-50. doi: 10.1159/000022425.Haemostasis. 1998.PMID:10420061Review.
- The prevalence of dementia in urban and rural areas of China.Jia J, Wang F, Wei C, Zhou A, Jia X, Li F, Tang M, Chu L, Zhou Y, Zhou C, Cui Y, Wang Q, Wang W, Yin P, Hu N, Zuo X, Song H, Qin W, Wu L, Li D, Jia L, Song J, Han Y, Xing Y, Yang P, Li Y, Qiao Y, Tang Y, Lv J, Dong X.Jia J, et al.Alzheimers Dement. 2014 Jan;10(1):1-9. doi: 10.1016/j.jalz.2013.01.012. Epub 2013 Jul 18.Alzheimers Dement. 2014.PMID:23871765
- Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation.Javanshiri K, Waldö ML, Friberg N, Sjövall F, Wickerström K, Haglund M, Englund E.Javanshiri K, et al.J Alzheimers Dis. 2018;65(4):1247-1258. doi: 10.3233/JAD-180644.J Alzheimers Dis. 2018.PMID:30149459
- Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs.Bowirrat A, Friedland RP, Farrer L, Baldwin C, Korczyn A.Bowirrat A, et al.J Mol Neurosci. 2002 Aug-Oct;19(1-2):239-45. doi: 10.1007/s12031-002-0040-4.J Mol Neurosci. 2002.PMID:12212789
- Facts, myths, and controversies in vascular dementia.Román GC.Román GC.J Neurol Sci. 2004 Nov 15;226(1-2):49-52. doi: 10.1016/j.jns.2004.09.011.J Neurol Sci. 2004.PMID:15537519Review.
Cited by
- Role of apolipoprotein E in neurodegenerative diseases.Giau VV, Bagyinszky E, An SS, Kim SY.Giau VV, et al.Neuropsychiatr Dis Treat. 2015 Jul 16;11:1723-37. doi: 10.2147/NDT.S84266. eCollection 2015.Neuropsychiatr Dis Treat. 2015.PMID:26213471Free PMC article.Review.
- The effect of scalp electroacupuncture combined with Memantine in patients with vascular dementia: A retrospective study.Yue A, Han X, Mao E, Wu G, Gao J, Huang L, Zhou B.Yue A, et al.Medicine (Baltimore). 2020 Aug 14;99(33):e21242. doi: 10.1097/MD.0000000000021242.Medicine (Baltimore). 2020.PMID:32871984Free PMC article.
- Aging, neurocognitive impairment and adherence to antiretroviral therapy in human immunodeficiency virus-infected individuals.Pinheiro CA, Mattos Souza LD, Motta JV, Kelbert EF, Martins CS, Souza MS, Pinheiro KA, Coelho FM, Pinheiro RT.Pinheiro CA, et al.Braz J Infect Dis. 2016 Nov-Dec;20(6):599-604. doi: 10.1016/j.bjid.2016.09.006. Epub 2016 Oct 24.Braz J Infect Dis. 2016.PMID:27789283Free PMC article.
- Management of mixed dementia.Zekry D, Gold G.Zekry D, et al.Drugs Aging. 2010 Sep 1;27(9):715-28. doi: 10.2165/11538250-000000000-00000.Drugs Aging. 2010.PMID:20809662Review.
- The dementing disorders.Hendrie HC, Unverzagt FW, Austrom MG.Hendrie HC, et al.Psychiatr Q. 1997 Fall;68(3):261-79. doi: 10.1023/a:1025488324153.Psychiatr Q. 1997.PMID:9237320Review.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources